Business
Medicure to present at Cantech Investment Conference
Medicure to present at Cantech Investment Conference Medicure to present at Cantec...
About this update from Medicure Inc.
[{"type":"text","content":"\n\n\n\nMedicure to present at Cantech Investment Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedicure to present at Cantech Investment Conference\nCanada NewsWire\nWINNIPEG, Jan. 21, 2016\n\n\n\nWINNIPEG, Jan. 21, 2016 /CNW/ - Medicure Inc. (\"Medicure\" or the \"Company\") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today announced that it will present at the 2016 Cantech Investment Conference on January 26th in Toronto.  \n\nNow entering its third year, The Cantech Investment Conference is where Canada's next great technology companies meet the investment community. The conference, brought to you by Cantech Letter and Cambridge House International, attracts public market investors, VCs, and angel investors for a one-day exhibit and presentation.\n\nThe conference will take place on January 26, 2016 from 8:00am to 6:00pm at the Metro Toronto Convention Centre.  Medicure's President and Chief Operating Officer, Mr. Dawson Reimer, will present on the TSX Stage at 1:45pm.  \n\nAbout Medicure Inc.\n\nMedicure is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for the U.S. hospital market. The primary focus of the Company and its subsidiaries is the marketing and distribution of AGGRASTAT (tirofiban HCl) for non-ST elevation acute coronary syndrome in the United States, where it is sold through the Company's U.S. subsidiary, Medicure Pharma, Inc.  For more information on Medicure please visit www.medicure.com.\n\nTo be added to Medicure's e-mail list, please visit:  http://medicure.mediaroom.com/alerts\n\nNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. \nSOURCE Medicure Inc.\n\n\n\n\n\n\nDawson Reimer, President & COO, Tel. 888-435-2220, Fax 204-488-9823, E-mail: [email protected], www.medicure.comCopyright CNW Group 2016","length":3538,"tagName":"div"}]